|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | ||||
| Provision for inventory reserve | ||||
| Provision for allowance for doubtful accounts | ||||
| Stock-based compensation | ||||
| Amortization of issuance and discount costs included in interest expense | ||||
| Accretion of discounts and amortization of issuance costs of convertible senior notes | ||||
| Deferred income taxes | ||||
| Other | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Inventory | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable, accrued expenses, and accrued payroll liabilities | ||||
| Net cash used in operating activities | ||||
| Investing activities | ||||
| Purchase of surgical instruments | ||||
| Purchase of property, plant and equipment | ||||
| Changes in cash restricted for leasehold improvements | ||||
| Purchase of intangible assets | ||||
| Net cash used in investing activities | ||||
| Financing activities | ||||
| Borrowings on bank line of credit | ||||
| Payments on bank line of credit | ||||
| Proceeds from issuance of convertible senior notes, net of issuance costs | ||||
| Proceeds from issuances of notes to stockholders | ||||
| Prepayment of notes to stockholders | ||||
| Payment of dividends on Series A and Series B redeemable convertible preferred stock | ||||
| Total payment of dividends on Series A and Series B redeemable convertible preferred stock | ||||
| Proceeds from issuances of common stock, net of issuance costs | ||||
| Proceeds from private placement of common stock | ||||
| Principal payments under capital lease | ||||
| Issuances and exercise of stock-based compensation benefit plans, net of income tax | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Net change in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of period | ||||
| Cash and cash equivalents at end of period | ||||
| Significant non-cash investing and financing activities | ||||
| Buildings under capital lease | ||||
| Leasehold improvements, including property under capital lease | ||||
| Additions to property, plant and equipment | ||||
| Capital lease obligation | ||||
| Accretion of discount on convertible senior notes | ||||
| Accretion of Series A and B redeemable convertible preferred stock | ||||
| Series A Redeemable Convertible Preferred Stock | ||||
| Series B Redeemable Convertible Preferred Stock | ||||
| Adjustment of preferred stock to fair value | ||||
| Common stock offering costs | ||||
| Cash paid for: | ||||
| Income taxes | ||||
| Interest | ||||
Loading...
